| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/560,665US8445011B2 (en) | 2010-07-08 | 2012-07-27 | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| US13/800,761US20130196012A1 (en) | 2010-11-30 | 2013-03-13 | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US13/847,940US8703184B2 (en) | 2010-07-08 | 2013-03-20 | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
| PCT/US2013/048627WO2014018223A1 (en) | 2012-07-27 | 2013-06-28 | Pharmaceutical formulation for bedwetting and method of use thereof |
| Publication Number | Publication Date |
|---|---|
| SG11201500601QAtrue SG11201500601QA (en) | 2015-04-29 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201500601QASG11201500601QA (en) | 2012-07-27 | 2013-06-28 | Pharmaceutical formulation for bedwetting and method of use thereof |
| SG11201500578VASG11201500578VA (en) | 2012-07-27 | 2013-06-28 | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201500578VASG11201500578VA (en) | 2012-07-27 | 2013-06-28 | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| Country | Link |
|---|---|
| US (3) | US20160022615A1 (en) |
| EP (3) | EP2844241A4 (en) |
| JP (4) | JP2015522658A (en) |
| KR (2) | KR20150048740A (en) |
| CN (4) | CN107335057A (en) |
| AU (3) | AU2013293488B2 (en) |
| BR (2) | BR112014031306A2 (en) |
| CA (2) | CA2879640A1 (en) |
| HK (4) | HK1205931A1 (en) |
| IL (3) | IL236028A0 (en) |
| MX (2) | MX2015001190A (en) |
| MY (1) | MY171526A (en) |
| RU (3) | RU2015106762A (en) |
| SG (2) | SG11201500601QA (en) |
| WO (2) | WO2014018222A1 (en) |
| ZA (2) | ZA201408993B (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017039832A1 (en)* | 2015-09-01 | 2017-03-09 | Wellesley Pharmaceuticals, Llc | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
| CN108430465A (en)* | 2015-09-30 | 2018-08-21 | 韦尔斯利医药有限公司 | Composition for alleviating frequent urination, its production method and use |
| EP3355864A4 (en)* | 2015-09-30 | 2019-05-22 | Wellesley Pharmaceuticals, LLC | COMPOSITION FOR REDUCING THE FREQUENCY OF MICTION, METHOD FOR MANUFACTURING AND USE THEREOF |
| TW201726114A (en)* | 2015-11-23 | 2017-08-01 | 魏斯理製藥公司 | Composition for reducing urinary frequency, preparation method thereof and application thereof |
| MX2019004191A (en)* | 2017-11-07 | 2020-02-12 | Poviva Tea Llc | Food and beverage compositions comprising pde5 inhibitors. |
| WO2022181625A1 (en) | 2021-02-23 | 2022-09-01 | Otsuka Pharmaceutical Co., Ltd. | Centanafadine pharmaceutical formulations, and methods of making and using same |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE306250T1 (en)* | 1998-12-23 | 2005-10-15 | Alza Corp | DOSAGE FORMS CONTAINING POROUS PARTICLES |
| WO2001017479A2 (en)* | 1999-09-09 | 2001-03-15 | Androsolutions, Inc. | Methods and compositions for preventing and treating prostate disorders |
| MXPA03001717A (en)* | 2000-08-30 | 2003-09-22 | Lilly Icos Llc | Method for treatment of migraine. |
| EP1437344A4 (en)* | 2001-09-28 | 2006-09-20 | Takeda Pharmaceutical | BENZOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE |
| PL372395A1 (en)* | 2002-02-19 | 2005-07-25 | Pharmacia Corporation | Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence |
| US7754767B2 (en)* | 2002-11-06 | 2010-07-13 | Trinity Laboratories, Inc. | Method for treatment of premature ejaculation in humans |
| CA2646729A1 (en)* | 2005-03-21 | 2006-09-28 | Dov Pharmaceutical, Inc. | Methods and compositions for the treatment of urinary incontinence |
| EP1741444A1 (en)* | 2005-07-05 | 2007-01-10 | Jerini AG | Kinin antagonists for treating bladder dysfunction |
| US20080166407A1 (en)* | 2005-07-29 | 2008-07-10 | Shalaby Shalaby W | Solid oral formulations for combination therapy |
| WO2007083323A2 (en)* | 2006-01-23 | 2007-07-26 | Panacea Biotec Limited. | Modified release oral dosage form comprising desmopressin |
| WO2007113243A2 (en)* | 2006-03-31 | 2007-10-11 | Investigación Y Clínica Andrológicas S.L. | Use of pde 5 inhibitors for the treatment of overactive bladder |
| CA2988753A1 (en)* | 2007-08-06 | 2009-02-12 | Serenity Pharmaceuticals, Llc | Methods and devices for desmopressin drug delivery |
| CN101664555A (en)* | 2008-09-02 | 2010-03-10 | 许洁 | Combined medicinal composition for treating infectious diseases of urogenital system |
| CN102028693A (en)* | 2009-09-30 | 2011-04-27 | 梁超峰 | Rectal administration composite containing 5-phosphodiesterase inhibitor |
| US9260424B2 (en)* | 2009-10-26 | 2016-02-16 | Auspex Pharmaceuticals, Inc. | 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase |
| US20120010294A1 (en)* | 2010-07-08 | 2012-01-12 | Dill David A | Compositions and methods for the inhibition of muscle contraction |
| US20120244221A1 (en)* | 2010-07-08 | 2012-09-27 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US20120141554A1 (en)* | 2010-07-08 | 2012-06-07 | Wellesley Pharmaceuticals, Llc | Delayed release formulation for reducing the frequency of urination and method of use thereof |
| US8236857B2 (en)* | 2010-07-08 | 2012-08-07 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| US8236856B2 (en)* | 2010-07-08 | 2012-08-07 | Wellesley Pharmaceuticals, Llc | Delayed release formulation for reducing the frequency of urination and method of use thereof |
| US20120135050A1 (en)* | 2010-07-08 | 2012-05-31 | Wellesley Pharmaceuticals, Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof |
| Publication | Publication Date | Title |
|---|---|---|
| IL253911A0 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| IL252566A0 (en) | Pharmaceutical compositions and methods | |
| ZA201401117B (en) | Kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof | |
| HRP20180953T1 (en) | Substituted 3-haloallylamine inhibitors of ssao and uses thereof | |
| IL234884A0 (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| ZA201401143B (en) | Capsule formulation comprising montelukast and levocetirizine | |
| IL230705A0 (en) | Certain kynurenine-3-monooxygenase inhibitors,pharmaceutical compositions,and methods of use thereof | |
| IL235831B (en) | Novel dosage form and formulation of abediterol | |
| ZA201403762B (en) | Delayed-release formulation for reducing the frequency of urination and method of use thereof | |
| PL2814463T3 (en) | Ophthalmic pharmaceutical compositions and methods of making and using same | |
| ZA201402820B (en) | Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof | |
| ZA201408993B (en) | Pharmaceutical formulation for bedwetting and method of use thereof | |
| IL235830A0 (en) | Novel dosage and formulation | |
| IL231505A0 (en) | Pharmaceutical composition and method of preparing same | |
| IL233961B (en) | Phytogenic nutraceutical composition and methods of use thereof | |
| GB201208315D0 (en) | Pharmaceutical methods and compositions | |
| HRP20180781T1 (en) | Pharmaceutical composition comprising lacidipine and process of preparation | |
| IL234614B (en) | Pharmaceutical composition and preparation method thereof | |
| GB201207064D0 (en) | Pharmaceutical compositions comprising 15-hetre and methods of using the same | |
| GB201219328D0 (en) | Game system and method of use thereof |